Secondary haemophagocytic lymphohistiocytosis (sHLH) and COVID-19
Secondary haemophagocytic lymphohistiocytosis (sHLH) is a hyperinflammatory syndrome that leads to fatal hyper cytokinaemia with multiorgan failure. It is characterized by unremitting fever, hyperferritinaemia, and cytopenias. Pulmonary involvement (ARDS) also occurs in 50% of patients. A cytokine profile similar to sHLH is associated with COVID-19 severity, and it is suggested through data on patients with elevated ferritin that hyperinflammation from SARS- CoV-2 is connected to mortalitiy.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Secondary Haemophagocytic Lymphiohistocytosis and COVID-19
Hyperinflammatory shock in children with family exposure to COVID-19
Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19
Vascular Hyperpemeability and Multi-organ failure in COVID-19
Secondary haemophagocytic lymphohistiocytosis (sHLH) and COVID-19
Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Cytokine Release Syndrome and COVID-19
COVID-19-Associated Hyperinflammation